CNS Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
CNS Pharmaceuticals, Inc. has filed 379 SEC EDGAR filings since 13 Mar 2018

SEC filing history

Showing 51-75 of 379 matching filings.

Per page
25
Current page
3
10-K/A File 001-39126

AMENDMENT NO. 1 TO FORM 10-K

Filing date
30 Apr 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
17 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
17 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
14 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
14 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 377-07866

UPLOAD filing

Filing date
11 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRSLTR

DRSLTR filing

Filing date
07 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS File 377-07866

DRS filing

Filing date
07 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
31 Mar 2025
Reporting date
31 Mar 2025
Next action
Verify source filing
10-K File 001-39126

FORM 10-K FOR DEC 2024

Filing date
31 Mar 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
424B5 File 333-279285

FORM 424B5

Filing date
20 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
21 Feb 2025
Reporting date
19 Feb 2025
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
03 Jan 2025
Reporting date
03 Jan 2025
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
11 Dec 2024
Reporting date
11 Dec 2024
Next action
Verify source filing
DEFR14A File 001-39126

DEFINITIVE REVISED PROXY SOLICITING MATERIALS

Filing date
15 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39126

FORM 10-Q FOR SEPT 2024

Filing date
14 Nov 2024
Reporting date
30 Sep 2024
Next action
Verify source filing
SC 13G/A File 005-93973

SC 13G/A filing

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39126

FORM DEF 14A

Filing date
28 Oct 2024
Reporting date
26 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
24 Oct 2024
Reporting date
23 Oct 2024
Next action
Verify source filing
424B5 File 333-279285

PROSPECTUS

Filing date
24 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .